Lv51
950 积分 2025-12-21 加入
Hypoglycemic Response to Dorzagliatin in a Patient With GCK-MODY
1小时前
待确认
Dorzagliatin monotherapy in Chinese patients with type 2 diabetes: a dose-ranging, randomised, double-blind, placebo-controlled, phase 2 study
3小时前
已完结
Chiglitazar in MASLD with hypertriglyceridemia and insulin resistance: A phase II, randomized, double-blind, placebo-controlled study
6小时前
已完结
Efficacy and safety of chiglitazar add‐on to metformin in type 2 diabetes mellitus ( RECAM study)
7小时前
已完结
皖公网安备34019202002308
